Literature DB >> 7724574

Identification of two flavivirus-like genomes in the GB hepatitis agent.

J N Simons1, T J Pilot-Matias, T P Leary, G J Dawson, S M Desai, G G Schlauder, A S Muerhoff, J C Erker, S L Buijk, M L Chalmers.   

Abstract

A subtractive PCR methodology known as representational difference analysis was used to clone specific nucleotide sequences present in the infectious plasma from a tamarin infected with the GB hepatitis agent. Eleven unique clones were identified, seven of which were examined extensively. All seven clones appeared to be derived from sequences exogenous to the genomes of humans, tamarins, Saccharomyces cerevisiae, and Escherichia coli. In addition, sequences from these clones were not detected in plasma or liver tissue of tamarins prior to their inoculation with the GB agent. These sequences were detected by reverse transcription-PCR in acute-phase plasma of tamarins inoculated with the GB agent. Probes derived from two of the seven clones detected an RNA species of > or = 8.3 kb in the liver of a GB-agent-infected tamarin by Northern blot hybridization. Sequence analysis indicated that five of the seven clones encode polypeptides that possess limited amino acid identity with the nonstructural proteins of hepatitis C virus. Extension of the sequences found in the seven clones revealed that plasma from an infected tamarin contained two RNA molecules > 9 kb long. Limited sequence identity with various isolates of hepatitis C virus and the relative positions of putative RNA helicases and RNA-dependent RNA polymerases in the predicted protein products of these molecules suggested that the GB agent contains two unique flavivirus-like genomes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724574      PMCID: PMC42174          DOI: 10.1073/pnas.92.8.3401

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Simplified northern blot hybridization using 5% sodium dodecyl sulfate.

Authors:  G D Virca; W Northemann; B R Shiels; G Widera; S Broome
Journal:  Biotechniques       Date:  1990-04       Impact factor: 1.993

3.  Sequencing the termini of capped viral RNA by 5'-3' ligation and PCR.

Authors:  C W Mandl; F X Heinz; E Puchhammer-Stöckl; C Kunz
Journal:  Biotechniques       Date:  1991-04       Impact factor: 1.993

4.  Morphology of the GB hepatitis agent.

Authors:  J D Almeida; F Deinhardt; A W Holmes; D A Peterson; L Wolfe; A J Zuckerman
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

5.  Lack of susceptibility of marmosets to human non-A, non-B hepatitis.

Authors:  E Tabor; L B Seeff; R J Gerety
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

6.  Studies of GB hepatitis agent in tamarins.

Authors:  P Karayiannis; L M Petrovic; M Fry; D Moore; M Enticott; M J McGarvey; P J Scheuer; H C Thomas
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

7.  Oligodeoxyribonucleotide ligation to single-stranded cDNAs: a new tool for cloning 5' ends of mRNAs and for constructing cDNA libraries by in vitro amplification.

Authors:  J B Edwards; J Delort; J Mallet
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

8.  Non-A, non-B hepatitis in chimpanzees and marmosets.

Authors:  S M Feinstone; H J Alter; H P Dienes; Y Shimizu; H Popper; D Blackmore; D Sly; W T London; R H Purcell
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

9.  Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C?

Authors:  J R Hibbs; N Frickhofen; S J Rosenfeld; S M Feinstone; S Kojima; A Bacigalupo; A Locasciulli; A G Tzakis; H J Alter; N S Young
Journal:  JAMA       Date:  1992-04-15       Impact factor: 56.272

10.  Human dopamine D1 receptor encoded by an intronless gene on chromosome 5.

Authors:  R K Sunahara; H B Niznik; D M Weiner; T M Stormann; M R Brann; J L Kennedy; J E Gelernter; R Rozmahel; Y L Yang; Y Israel
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

View more
  118 in total

1.  Approaches of the diagnosis of hepatitis viruses.

Authors:  G J Kotwal
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

2.  Immunogenicity of HGV NS5 protein expressed from Sf9 insect cells.

Authors:  H Ren; F L Zhu; S Y Zhu; Y Song; Z T Qi
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species.

Authors:  T Allander; S U Emerson; R E Engle; R H Purcell; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

4.  Existence of distinct GB virus C/hepatitis G virus variants with different tropism.

Authors:  M Fogeda; J M López-Alcorocho; J Bartolomé; C Arocena; M A Martín; V Carreño
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus.

Authors:  B Beames; D Chavez; B Guerra; L Notvall; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  A B C d e f g ...

Authors:  S Shafran; J Conly
Journal:  Can J Infect Dis       Date:  1996-05

7.  Evidence against GB virus C infection in dromedary camels.

Authors:  Jack T Stapleton; Donald B Smith; Peter Simmonds
Journal:  Vet Microbiol       Date:  2011-06-30       Impact factor: 3.293

8.  Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features.

Authors:  Steeve Boulant; Christophe Vanbelle; Christine Ebel; François Penin; Jean-Pierre Lavergne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins.

Authors:  Shingo Takikawa; Ronald E Engle; Kristina N Faulk; Suzanne U Emerson; Robert H Purcell; Jens Bukh
Journal:  J Gen Virol       Date:  2009-11-11       Impact factor: 3.891

10.  GBV-C RNA presence in several high-risk groups of Spain.

Authors:  E Quirós; G Piédrola; M C Maroto
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.